Interactive tools

Addressing Delays in Prior Authorization Processes That Negatively Impact Patients

Emerging Topical Alternatives to Hydroquinone in Melasma Management

JAK Inhibitors Show Comparable Safety to TNF Antagonists

Phase 2 Nemolizumab Trial Opens for CPUO

"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions

Mohs Micrographic Surgery in High-Profile Patients: A Call for Expanding Access to Skin Cancer Care

The SkinCARE Questionnaire: Assessing the Psychological Dimensions of Skin Health Beyond Disease

Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control

FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol

Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population